Atlas Trials

Efficacy of Rifaximin to Treat Diarrhea-predominant Irritable Bowel Syndrome

Clinical trial NCT02565654 · UNKNOWN

Trial details

NCT number
NCT02565654
Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Status
UNKNOWN
Study type
OBSERVATIONAL
Irritable Bowel Syndrome
Start date
2015-10-01
Primary completion
2017-10-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.